Skip to content

Effectiveness of Homoeopathic medicines in treatment of Rheumatoid Arthritis selected using Boenninghausen Characteristic Repertory by CM Boger

Effectiveness of Homoeopathic Remedies selected based on Boger Boenninghausen Characteristics and Repertory (BBCR) in the treatment of Rheumatoid Arthritis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055692
Enrollment
40
Registered
2023-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: HOMOEOPATHIC MEDICINE SELECTED AFTER REPERTORISATION USING BOENNINGHAUSEN CHARACTERISTICS AND REPERTORY BY Dr.C.M.BOGER: Patients who have diagnosed as RA according ACR/EULAR RA classif

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with RA according to the ACR-EULAR classification criteria. 2. Cases with characteristic particular symptoms suitable for Repertorisation in Boger Boenninghausenâ??s Characteristics and Repertory (BBCR). 3. Age between 25-55 years 4. Patients of all gender 5. patients belonging to all religion and socioeconomic group 6. Both male and female patients. 7. Patient willing to take part in the study and giving informed consent.

Exclusion criteria

Exclusion criteria: 1. Currently receiving homoeopathic treatment for any chronic condition(s). 2. Patients with known comorbidities viz. diabetes mellitus, hypertension serious systemic unevaluated or uncontrolled diseases affecting quality of life or on other treatment therapies; psychiatric illness and continuing with medication for this kind will be excluded during screening. 3. Patients taking Steroid medicines for RA 4. Substance abuse and/or dependence. 5. Self-reported immune-compromised state. 6. Pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
Rheumatoid Arthritis Assessment Score RAASTimepoint: At baseline & 6 month

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr.Binod Kumar Bhagat

National Institute of Homoeopathy

dr.binodkbhagat@gmail.com8210003741

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026